Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent GBM: A Retrospective Patient Chart Review

NCT04974983 is registered in ClinicalTrials.gov with University Hospital Regensburg as lead sponsor.

NCT NCT04974983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent GBM: A Retrospective Patient Chart Review
Lead sponsor
University Hospital Regensburg
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
August 30, 2020
Enrollment
203 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiogenesis, glioblastoma